Literature DB >> 13299333

The suppression of Paget's disease with ACTH and cortisone.

F ALBRIGHT, P H HENNEMAN.   

Abstract

Entities:  

Keywords:  ACTH/therapeutic use; CORTISONE/therapeutic use; OSTEITIS DEFORMANS/therapy

Mesh:

Substances:

Year:  1955        PMID: 13299333

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN: 0066-9458


× No keyword cloud information.
  8 in total

1.  Medical staff conference. Paget disease of bone.

Authors: 
Journal:  West J Med       Date:  1978-09

2.  THE EFFECTS OF SODIUM FLORIDE ON CALCIUM METABOLISM OF SUBJECTS WITH METABOLIC BONE DISEASES.

Authors:  C RICH; J ENSINCK; P IVANOVICH
Journal:  J Clin Invest       Date:  1964-04       Impact factor: 14.808

3.  Strontium and calcium metabolism in metabolic bone diseases.

Authors:  E C DOW; J B STANBURY
Journal:  J Clin Invest       Date:  1960-06       Impact factor: 14.808

4.  Clinical and biochemical studies of Paget's disease of bone with emphasis on the effects of RNA inhibitors actinomycin D and mithrawycin.

Authors:  J J Fennelly
Journal:  Ir J Med Sci       Date:  1971-10       Impact factor: 1.568

5.  Paget's disease of bone.

Authors:  E S Siris; T P Jacobs; R E Canfield
Journal:  Bull N Y Acad Med       Date:  1980-04

6.  Paget's disease; changes occurring following treatment with newer hormonal agents.

Authors:  F O KOLB
Journal:  Calif Med       Date:  1959-11

7.  Treatment of Paget's disease of bone with synthetic salmon calcitonin.

Authors:  J A Kanis; D B Horn; R D Scott; J A Strong
Journal:  Br Med J       Date:  1974-09-21

8.  Treatment of Paget's disease of bone with mithramycin.

Authors:  J R Condon; S B Reith; J R Nassim; F J Millard; A Hilb; E M Stainthorpe
Journal:  Br Med J       Date:  1971-02-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.